Rome, Italy

Patrizia Natale


Average Co-Inventor Count = 2.0

ph-index = 3

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 1997-2008

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Patrizia Natale

Introduction

Patrizia Natale is a prominent inventor based in Rome, Italy. She has made significant contributions to the field of biotechnology, particularly in the development of liquid formulations for interferon-beta. With a total of 4 patents to her name, her work has the potential to impact therapeutic applications significantly.

Latest Patents

Among her latest patents, Patrizia Natale has developed interferon-beta liquid formulations that are stabilized with a polyol, a non-reducing sugar, or an amino acid. These formulations are particularly noteworthy for their stabilization with mannitol, a polyol. Additionally, they include a buffer, such as acetate buffer, with a pH range between 3.0 and 4.0, and a minimum quantity of human albumin. The interferon-beta used in these formulations is preferably recombinant, showcasing her innovative approach to enhancing the stability and efficacy of these therapeutic agents.

Career Highlights

Patrizia Natale is associated with Applied Research Systems Ars Holding N.V., where she continues to push the boundaries of research and development in her field. Her work is characterized by a commitment to improving the formulation and delivery of biopharmaceuticals, which is crucial for patient care and treatment outcomes.

Collaborations

Patrizia collaborates with Fabrizio Samaritani, leveraging their combined expertise to advance their research initiatives. Their partnership exemplifies the collaborative spirit that drives innovation in the scientific community.

Conclusion

Patrizia Natale's contributions to the field of biotechnology through her innovative patents and collaborative efforts highlight her role as a leading inventor. Her work not only advances scientific knowledge but also holds promise for improving therapeutic applications in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…